Article
Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs.
Journal of molecular and cellular cardiology - 1 Jan 2020
Stroik Daniel R, Ceholski Delaine K, Bidwell Philip A, Mleczko Justyna, Thanel Paul F, Kamdar Forum, Autry Joseph M, Cornea Razvan L, Thomas David D
Abstract excerpt
There is increasing momentum toward the development of gene therapy for heart failure (HF) that is defined by impaired calcium (Ca2+) transport and reduced contractility. We have used FRET (fluorescence resonance energy transfer) between fluorescently-tagged SERCA2a (the cardiac Ca2+ pump) and PLB (phospholamban, ventricular peptide inhibitor of SERCA) to test directly the effectiveness of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
